Prediction of herb-drug interaction: the combination of Gumiganghwal-tang and montelukast for the treatment of asthma

topic. Korean clinical trials were done on dyslipidemia(n=2) and diabetes(n=1). Significant adverse effectswere null in clinical studies. Methodological quality of the studieswere varied. Gastrointestinal, antidiabetic, and dermatologic useswere not mentioned in traditional literature or had very small numbers of citations. These uses are identified as potential areas for reinvestigation and reintroduction to Koreanmedical practice. Conclusion: There is potential for different uses of Mori folium in Korean medicine in addition to the current clinical landscape. More clinical research from the Koreanmedical point of view is needed. Contact: Eun sang Jeon, ihsanjeon@gmail.com